Associations between BODE Index and Systemic Inflammatory Biomarkers in COPD
暂无分享,去创建一个
K. Kostikas | K. Gourgoulianis | S. Loukides | A. Papaioannou | S. Papiris | M. Alchanatis | P. Bakakos | E. Gaki | K. Kontogianni
[1] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[2] H. Reddel,et al. American Thoracic Society , 2001 .
[3] P. Bakke,et al. Body composition and plasma levels of inflammatory biomarkers in COPD , 2010, European Respiratory Journal.
[4] K. Kostikas,et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD. , 2010, Respiratory medicine.
[5] K. Kostikas,et al. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers. , 2010, Respiratory medicine.
[6] P. J. Barnes,et al. Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.
[7] N. Koulouris,et al. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. , 2007, Chest.
[8] T. Itoh,et al. Elevated circulating plasma adiponectin in underweight patients with COPD. , 2007, Chest.
[9] M. Polkey,et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease , 2007, Respiratory research.
[10] A. A. Romanovsky,et al. Leptin: at the crossroads of energy balance and systemic inflammation. , 2007, Progress in lipid research.
[11] C. Russell,et al. Acute and chronic regulation of leptin synthesis, storage, and secretion by insulin and dexamethasone in human adipose tissue. , 2007, American journal of physiology. Endocrinology and metabolism.
[12] John R Hurst,et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.
[13] S. Rubin,et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects , 2005, Thorax.
[14] E. Wouters,et al. Raised CRP levels mark metabolic and functional impairment in advanced COPD , 2005, Thorax.
[15] B. Nordestgaard,et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. , 2006, American journal of respiratory and critical care medicine.
[16] C. Meier,et al. Adipose tissue: a regulator of inflammation. , 2005, Best practice & research. Clinical endocrinology & metabolism.
[17] C. Prefaut,et al. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress , 2005, European Respiratory Journal.
[18] E. Wouters,et al. Body composition and mortality in chronic obstructive pulmonary disease. , 2005, American Journal of Clinical Nutrition.
[19] D. Sin,et al. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[20] Ciro Casanova,et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[21] A. Schols. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management , 2003, European Respiratory Journal.
[22] A. Schols. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease , 2003, Proceedings of the Nutrition Society.
[23] L. Bouter,et al. How to measure comorbidity. a critical review of available methods. , 2003, Journal of clinical epidemiology.
[24] X. Busquets,et al. Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[25] T. Erselcan,et al. Comparison of Body Composition Analysis Methods in Clinical Routine , 2000, Annals of Nutrition and Metabolism.
[26] P. Jones,et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.
[27] H. Saito,et al. Circulating leptin in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[28] E. Wouters,et al. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[29] R. Rogers,et al. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.
[30] John L. Hankinson,et al. Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[31] S. Heymsfield,et al. Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. , 1990, The American journal of clinical nutrition.
[32] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[33] H C Lukaski,et al. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. , 1985, The American journal of clinical nutrition.